FI970702A0 - Estradiol-TTS med vattenbindande tillsatsämnen - Google Patents

Estradiol-TTS med vattenbindande tillsatsämnen

Info

Publication number
FI970702A0
FI970702A0 FI970702A FI970702A FI970702A0 FI 970702 A0 FI970702 A0 FI 970702A0 FI 970702 A FI970702 A FI 970702A FI 970702 A FI970702 A FI 970702A FI 970702 A0 FI970702 A0 FI 970702A0
Authority
FI
Finland
Prior art keywords
water
binding additives
hydrophylic
additive
tts
Prior art date
Application number
FI970702A
Other languages
English (en)
Finnish (fi)
Other versions
FI970702A (sv
FI118721B (sv
Inventor
Michael Horstmann
Walter Mueller
Hanshermann Franke
Thomas Pontzen
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of FI970702A0 publication Critical patent/FI970702A0/sv
Publication of FI970702A publication Critical patent/FI970702A/sv
Application granted granted Critical
Publication of FI118721B publication Critical patent/FI118721B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI970702A 1994-08-20 1997-02-19 Estradiol-TTS med vattenbindande tillsatsämnen FI118721B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4429664 1994-08-20
DE4429664A DE4429664C2 (de) 1994-08-20 1994-08-20 Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung
PCT/EP1995/003202 WO1996005815A1 (de) 1994-08-20 1995-08-12 Estradiol-tts mit wasserbindenden zusätzen
EP9503202 1995-08-12

Publications (3)

Publication Number Publication Date
FI970702A0 true FI970702A0 (sv) 1997-02-19
FI970702A FI970702A (sv) 1997-02-19
FI118721B FI118721B (sv) 2008-02-29

Family

ID=6526229

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970702A FI118721B (sv) 1994-08-20 1997-02-19 Estradiol-TTS med vattenbindande tillsatsämnen

Country Status (21)

Country Link
EP (1) EP0776197B1 (sv)
JP (1) JPH10504314A (sv)
KR (1) KR100374476B1 (sv)
CN (1) CN1073413C (sv)
AT (1) ATE173163T1 (sv)
AU (1) AU700119B2 (sv)
CA (1) CA2197865C (sv)
CZ (1) CZ50897A3 (sv)
DE (2) DE4429664C2 (sv)
DK (1) DK0776197T3 (sv)
ES (1) ES2126308T3 (sv)
FI (1) FI118721B (sv)
HU (1) HUT77093A (sv)
IL (1) IL114948A (sv)
NO (1) NO970553D0 (sv)
NZ (1) NZ291449A (sv)
PL (1) PL180943B1 (sv)
SI (1) SI0776197T1 (sv)
SK (1) SK280299B6 (sv)
WO (1) WO1996005815A1 (sv)
ZA (1) ZA956926B (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6623763B2 (en) 1996-01-08 2003-09-23 Lts Lohmann Therape-System Ag Pharmaceutical preparation adhering to the skin, in particular a transdermal therapeutic system for the release of 17-β-estradiol to the human organism
DE19600347A1 (de) * 1996-01-08 1997-07-10 Lohmann Therapie Syst Lts Hauthaftende pharmazeutische Zubereitung, insbesondere TTS zur Abgabe von 17-beta-Estradiol an den menschlichen Organismus
GB9720470D0 (en) 1997-09-25 1997-11-26 Ethical Pharmaceuticals South Inhibition of crystallization in transdermal devices
DE19827732A1 (de) * 1998-06-22 1999-12-23 Rottapharm Bv Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6712090A (en) * 1989-10-13 1991-05-16 Watson Laboratories, Inc. Drug delivery systems and matrix therefor
DE4223360C1 (sv) * 1992-07-16 1993-04-08 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
DE4237453C1 (sv) * 1992-11-06 1993-08-19 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
DE4309830C1 (de) * 1993-03-26 1994-05-05 Lohmann Therapie Syst Lts Wirkstoffpflaster für die Abgabe von Estradiol an die Haut

Also Published As

Publication number Publication date
SK21997A3 (en) 1997-07-09
PL180943B1 (pl) 2001-05-31
DE4429664A1 (de) 1996-02-22
KR970705380A (ko) 1997-10-09
PL319014A1 (en) 1997-07-21
WO1996005815A1 (de) 1996-02-29
NO970553L (no) 1997-02-06
NO970553D0 (no) 1997-02-06
CA2197865A1 (en) 1996-02-29
DE59504233D1 (de) 1998-12-17
ZA956926B (en) 1996-03-25
CA2197865C (en) 2005-10-25
MX9701301A (es) 1998-05-31
NZ291449A (en) 1998-09-24
CZ50897A3 (en) 1997-06-11
CN1073413C (zh) 2001-10-24
HUT77093A (hu) 1998-03-02
EP0776197B1 (de) 1998-11-11
FI970702A (sv) 1997-02-19
ES2126308T3 (es) 1999-03-16
AU3258395A (en) 1996-03-14
DK0776197T3 (da) 1999-07-26
SI0776197T1 (en) 1999-04-30
DE4429664C2 (de) 1997-09-11
CN1155836A (zh) 1997-07-30
JPH10504314A (ja) 1998-04-28
IL114948A (en) 2000-10-31
EP0776197A1 (de) 1997-06-04
FI118721B (sv) 2008-02-29
SK280299B6 (sk) 1999-11-08
ATE173163T1 (de) 1998-11-15
KR100374476B1 (ko) 2003-04-23
IL114948A0 (en) 1995-12-08
AU700119B2 (en) 1998-12-24

Similar Documents

Publication Publication Date Title
IE800059L (en) Polymeric diffusion matrix
DK1014954T3 (da) Transdermalt terapeutisk system
FI844799L (fi) Frigoeringssystem foer verkningsmedel.
ATE95430T1 (de) Wirkstoffpflaster.
WO1997004818A3 (de) Transdermales therapeutisches system zur abgabe von wirkstoffen über die haut an den menschlichen körper
FI961282A0 (sv) Transdermalt terapeutiskt system med acetylsalicylsyra som verksamt ämne
WO1998036740A3 (de) Transdermales oder topisches pflastersystem mit polyacrylatmatrix mit verbesserten physikalischen eigenschaften
FI970702A (sv) Estradiol-TTS med vattenbindande tillsatsämnen
MX9701302A (es) Sistema terapeutico transdermico de estradiol que comprende aditivos higroscopicos.
HUP0003347A2 (hu) Transzdermális terápiás rendszer (TTS) hatóanyag leadásához és eljárás a bőrre történő alkalmazáshoz
DE59509643D1 (de) Transdermales therapeutisches system mit hydrolyseschutz
GR3032219T3 (en) Surface-stabilised pharmaceutical preparation for application on the skin
CA2197867A1 (en) Oestradiol transdermal therapeutic system comprising hygroscopic additives

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 118721

Country of ref document: FI

MM Patent lapsed